Suppr超能文献

睾酮补充治疗与枸橼酸氯米酚治疗性腺功能减退症:年龄匹配的满意度和疗效比较。

Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy.

机构信息

Department of Urology, Baylor College of Medicine, Houston, Texas.

Department of Urology, Baylor College of Medicine, Houston, Texas.

出版信息

J Urol. 2014 Sep;192(3):875-9. doi: 10.1016/j.juro.2014.03.089. Epub 2014 Mar 21.

Abstract

PURPOSE

We compared satisfaction and treatment efficacy in men with symptomatic hypogonadism who received clomiphene citrate or testosterone supplementation therapy.

MATERIALS AND METHODS

Men treated with clomiphene citrate, or testosterone injections or gels for symptomatic hypogonadism (total testosterone less than 300 ng/dl) reported satisfaction with the current treatment regimen using the qADAM questionnaire.

RESULTS

A total of 93 men on testosterone injections (31) or gels (31), or clomiphene citrate (31) were age matched from a retrospective cohort of 1,150 on testosterone supplementation therapy. We compared men who received testosterone supplementation therapy to 31 not on such therapy, who served as controls. Median serum testosterone increased from pretreatment levels in all men regardless of therapy with clomiphene citrate, and testosterone injections and gels (from 247 to 504, 224 to 1,104 and 230 to 412 ng/dl, respectively, p <0.05). Final median serum total testosterone in men on clomiphene citrate (504 ng/dl) was lower than in men receiving testosterone injections (1,014 ng/dl, p <0.01) but similar to that in men on testosterone gels (412 ng/dl, p = 0.31). Despite different serum testosterone levels men on all 3 therapies reported similar satisfaction on qADAM, including a score of 35 for clomiphene citrate, 39 for testosterone injections, 36 for testosterone gels and 34 for control treatment (p >0.05). Men receiving testosterone injections reported greater libido than men on clomiphene citrate (4 vs 3, p = 0.04) or testosterone gels (4 vs 3, p = 0.04), or controls (4 vs 3, p <0.01).

CONCLUSIONS

Testosterone supplementation regimens and clomiphene citrate are efficacious for improving serum total testosterone. No difference in overall hypogonadal symptoms was noted among men on any testosterone supplementation therapy. Despite lower serum total testosterone, men on clomiphene citrate and testosterone gels reported satisfaction similar to that of men treated with testosterone injections.

摘要

目的

我们比较了接受枸橼酸氯米酚或睾酮补充治疗的有症状性腺功能减退症男性的满意度和治疗效果。

材料和方法

接受枸橼酸氯米酚或睾酮注射或凝胶治疗有症状性腺功能减退症(总睾酮<300ng/dl)的男性使用 qADAM 问卷报告对当前治疗方案的满意度。

结果

从接受睾酮补充治疗的 1150 名男性的回顾性队列中,年龄匹配了 93 名接受睾酮注射(31 名)或凝胶(31 名)或枸橼酸氯米酚(31 名)的男性。我们将接受睾酮补充治疗的男性与 31 名未接受此类治疗的男性进行比较,这些男性作为对照组。无论接受枸橼酸氯米酚治疗还是睾酮注射和凝胶治疗,所有男性的血清睾酮中位数均从治疗前水平升高(分别从 247 至 504、224 至 1104 和 230 至 412ng/dl,p<0.05)。接受枸橼酸氯米酚治疗的男性的最终中位血清总睾酮(504ng/dl)低于接受睾酮注射的男性(1014ng/dl,p<0.01),但与接受睾酮凝胶治疗的男性相似(412ng/dl,p=0.31)。尽管血清睾酮水平不同,但接受所有 3 种治疗的男性在 qADAM 上报告的满意度相似,包括枸橼酸氯米酚的评分 35 分、睾酮注射的评分 39 分、睾酮凝胶的评分 36 分和对照组的评分 34 分(p>0.05)。接受睾酮注射的男性的性欲评分高于接受枸橼酸氯米酚(4 分对 3 分,p=0.04)或睾酮凝胶(4 分对 3 分,p=0.04)或对照组(4 分对 3 分,p<0.01)的男性。

结论

睾酮补充方案和枸橼酸氯米酚可有效改善血清总睾酮。接受任何睾酮补充治疗的男性的总体性腺功能减退症状无差异。尽管血清总睾酮较低,但接受枸橼酸氯米酚和睾酮凝胶治疗的男性报告的满意度与接受睾酮注射治疗的男性相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验